Interestingly, recent studies have also shown the prognostic value for B cell infiltrates in patient outcomes (57) as well as a role for Th1 cells in promoting B-cell function and activity (135), suggesting an intriguing and important role for SYNGR3-expressing B cells in modifying the tumor immune microenvironment. The gene discussed is SYNGR3; the disease is neoplasm.